PROTHENA CORP PUBLIC LTD CO PRTA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-12-21
PROTHENA CORP PUBLIC LTD CO statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -2216.4% | -114.4% | -209.1% | -244.1% | 35.9% | -13216.2% | -10527.9% | -16634.0% | -564.2% | -15121.8% |
| Net margin | -2520.6% | -90.5% | -160.9% | -217.0% | 33.4% | -13029.8% | -9542.6% | -16297.9% | -556.8% | -15176.1% |
| Return on assets | -74.7% | -22.4% | -21.1% | -15.4% | 11.0% | -33.4% | -18.5% | -31.2% | -30.9% | -34.8% |
| Return on equity | -87.0% | -25.1% | -26.2% | -18.8% | 14.4% | -60.4% | -28.5% | -48.2% | -37.6% | -43.8% |
| Current ratio | 7.72 | 10.01 | 11.24 | 14.34 | 17.48 | 11.58 | 21.36 | 28.90 | 11.41 | 9.53 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.